AstraZeneca Misses Q3 Earnings Consensus, Expects COVID-19 Vaccine Trial Results This Year

AstraZeneca Plc missed earnings expectations in the third quarter of 2020.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.